Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.

@article{Ensor2002PegylatedAD,
  title={Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.},
  author={Charles Mark Ensor and Frederick W. Holtsberg and John Stephen Bomalaski and Mike Clark},
  journal={Cancer research},
  year={2002},
  volume={62 19},
  pages={5443-50}
}
Some murine melanomas and hepatocellular carcinomas (HCCs) have been shown to be auxotrophic for arginine. Arginine deiminase (ADI; EC 3.5.3.6.), an arginine-degrading enzyme isolated from Mycoplasma, can inhibit growth of these tumors. We found that ADI was specific for arginine and did not degrade other amino acids. Although arginine is not an essential amino acid for most cells, all human melanomas and HCCs tested were found to be inhibited by ADI in vitro. Arginine is synthesized from… CONTINUE READING
Highly Influential
This paper has highly influenced 11 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 102 extracted citations

L-arginine biosensors: A comprehensive review

Biochemistry and biophysics reports • 2017
View 5 Excerpts
Highly Influenced

Argininosuccinate synthase: at the center of arginine metabolism.

International journal of biochemistry and molecular biology • 2011
View 4 Excerpts
Highly Influenced

Nonessential amino acid metabolism in breast cancer.

Advances in biological regulation • 2016
View 11 Excerpts
Highly Influenced

Arginine deprivation therapy for malignant melanoma

Clinical pharmacology : advances and applications • 2013
View 4 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 20 references

Formulation of arginine deiminase with polyethylene glycol (peg): effects of different linkers and molecular weight of PEG on the pharmacokinetics, pharmacodynamics and immunogenicity of this enzyme

F. W. Holtsberg, C. M. Ensor, J. S. Bomalaski, M. A. Clark
J. Controlled Release, • 2002
View 1 Excerpt

Use of L-asparaginase in childhood ALL.

Critical reviews in oncology/hematology • 1998

Species variation in arginine requirements

Q. R. Rogers
1994

Similar Papers

Loading similar papers…